Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Revista Colombiana de Cardiología
Print version ISSN 0120-5633
Abstract
VELASQUEZ, Camilo A.; GONZALEZ, Miguel; BERROUET, Marie C. and JARAMILLO, Nicolás. Chemotherapy-induced cardiotoxicity from molecular bases to clinical perspective. Rev. Colomb. Cardiol. [online]. 2016, vol.23, n.2, pp.104-111. ISSN 0120-5633. https://doi.org/10.1016/j.rccar.2015.10.002.
Nowadays cancer represents an epidemic that can be considered a public health problem. That is why pharmacological development has emerged for improving survival and remission rates. Nevertheless, this has been obscured by the toxicity of these therapies. Cardiotoxicity is a known adverse event of oncologic therapy that many times limits a correct regimen of administration thus lowering efficacy; therefore, understanding pathophysiological and molecular bases is essential in order to determine preventive and therapeutical measures that can allow a reduction in the incidence of toxicity, without interfering in the efficacy of the cancer therapy. We hereby describe a review of the adverse effects of chemotherapy in the cardiac system, from molecular bases to clinical implications.
Keywords : Heart; Complications; Cardiac failure; Treatment; Free radicals.